Insulin-like growth factor receptor cooperates with integrin αvβ5 to promote tumor cell dissemination in vivo

Journal of Clinical Investigation

Volumn 99, Issue 6, 1997, Pages 1390-1398

  Brooks, Peter C ^a   Klemke, Richard L ^a   Schön, Silvia ^a   Lewis, Jean M ^a   Schwartz, Martin A ^a   Cheresh, David A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

adhesion; cytokine; invasion; motility; actinin

Indexed keywords

ALPHA ACTININ; INTEGRIN; SOMATOMEDIN RECEPTOR; VITRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR CELL;

EID: 0030901145     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119298     Document Type: Article

References (51)

1. Blood, C.H., and B.R. Zetter. 1990. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032:89-118.
2. Liotta, L.A., P.S. Steeg, and W.G. Stetler-Stevenson. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:327-336.
3. Herlyn, M., and S.B. Malkowicz. 1991. Biology of disease: regulatory pathways in tumor growth and invasion. Lab. Invest. 65:262-271.
4. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269:31807-31813.
5. Chan, B.M.C., N. Matsuura, Y. Takada, B.R. Zetter, and M.E. Hemler. 1991. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science (Wash. DC). 251:1600-1602.
6. Nip, J., H. Shibata, D.J. Loskutoff, D.A. Cheresh, and P. Brodt. 1992. Human melanoma cells derived from lymphatic metastases use integrin ανβ3 to adhere to lymph node vitronectin. J. Clin. Invest. 90:1406-1413.
7. Nip, J., and J. Brodt. 1995. The role of integrin vitronectin receptor ανβ3 in melanoma metastasis. Cancer Metastasis Rev. 14:241-252.
8. Seftor, R.E.B., E.A. Seftor, K.R. Gehlsen, W.G. Stetler-Stevenson, P.D. Brown, E. Ruoslahti, and M.J.C. Hendrix. 1992. Role of the ανβ3 integrin in human melanoma cell invasion. Proc. Natl. Acad. Sci. USA. 89:1557-1561.
9. Akiyama, S.K., K. Olden, and K.M. Yamada. 1995. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14:173-189.
10. Wayner, E.A., R.A. Orlando, and D.A. Cheresh. 1991. Integrins ανβ3 and ανβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. Cell Biol. 113:919-929.
11. Felding-Habermann, B., B.M. Mueller, C.A. Romerdahl, and D.A. Cheresh. 1992. Involvement of integrin αν gene expression in human melanoma tumorgenicity. J. Clin. Invest. 89:2018-2022.
12. Luna, E.J., and A.L. Hitt. 1992. Cytoskeleton plasma membrane interactions. Science (Wash. DC). 258:955-964.
13. Haimovich, B., L. Lipfert, J.S. Brugge, and S.J. Shattil. 1993. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J. Biol. Chem. 268:15868-15877.
14. Plopper, G.E., H.P. McNamee, L.E. Dike, K. Bojanowski, and D.E. Ingber. 1995. Convergence of integrin and growth factor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6:1349-1365.
15. Miyamoto, S., H. Teramoto, O.A. Coso, J.S. Gutkind, P.D. Burbelo, S.K. Akiyama, and K.M. Yamada. 1995. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131:791-805.
16. Klemke, R.L., M. Yebra, E.M. Bayna, and D.A. Cheresh. 1994. Receptor tyrosine kinase signaling required for integrin ανβ5-direcled cell motility but not adhesion on vitronectin. J. Cell Biol. 127:850-866.
17. Filardo, E.J., P.C. Brooks, S.L. Deming, C. Damsky, and D.A. Cheresh. 1995. Requirement of the NPXY motif in the integrin β3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130:441-450.
18. Stracke, M.L., E.C. Kohn, S.A. Aznavoorian, L.L. Wilson, D. Salomon, H.C. Kutzsch, L.A. Liotta, and E. Schiffmann. 1988. Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem. Biophys. Res. Commun. 153:1076-1083.
19. Stracke, M.L., J.D. Engel, L.W. Wilson, M.M. Rechler, L.A. Liotta, and E. Schiffmann. 1989. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J. Biol. Chem. 264:21544-21549.
20. Rodeck, U., K. Melbor, R. Kath, H.-D. Menssen, M. Varello, B. Atkinson, and M. Herlyn. 1991. Constitutive expression of multiple growth factor genes by melanoma cells hut not normal melanocytes. J. Invest. Dermatol. 97: 20-26.
21. Rodeck, U., and M. Heryln. 1991. Growth factors in melanoma. Cancer Metastasis Rev. 10:89-101.
22. Matsumoto, K., B.L. Ziober, C.-C. Yao, and R.H. Kramer. 1995. Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Rev. 14:205-217.
23. cdc2. Cancer Res. 54:5531-5534.
24. Cheresh, D.A., J.W. Smith, H.M. Cooper, and V. Quaranta. 1989. A novel vitronectin receptor integrin (ανβx) is responsible for distinct adhesive properties of carcinoma cells. Cell. 57:59-69.
25. Yatohgo, T., M. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13:281-292.
26. Wickham, T.J., E.J. Filardo, D.A. Cheresh, and G.R. Nemerow. 1994. Integrin ανβ5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:257-264.
27. Brooks, P.C., S. Stromblad, R.L. Klemke, D. Visscher, F.H. Sarker, and D.A. Cheresh. 1995. Antiintegrin ανβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96:1815-1822.
28. Lewis, J.M., and M.A. Schwartz. 1995. Mapping in vivo associations of cytoplasmic proteins with integrin β1 cytoplasmic domain mutants. Mol. Biol. Cell. 6:151-160.
29. Brooks, P.C., J.-M. Lin, D.L. French, and J.P. Quigley. 1993. Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis. J. Cell Biol. 122:1351-1359.
30. Yan, H.-C., I. Juhasz, J. Pile, G.F. Murphy, M. Heryln, and S.M. Albelda. 1993. Human/severe combined immunodeficient mouse chimeras. J. Clin. Invest. 91:986-996.
31. Brooks, P.C., A.M.P. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier, and D. A. Cheresh. 1994. Integrin ανβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
32. Doerr, M.E., and J.L. Jones. 1996. The role of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271:2443-2447.
33. Morton, D.M., and R. Tchao. 1994. Regulation of motility and cytoskeletal organization of rat bladder carcinoma cells by cyclic AMP. Cell Motil. Cytoskeleton. 29:375-382.
34. Juliano, R. 1994. Signal transduction by integrins and its role in the regulation of tumor growth. Cancer Metastasis Rev. 13:25-30.
35. Dedhar, S. 1995. Integrin mediated signal transduction in oncogenesis: an overview. Cancer Metastasis Rev. 145:165-172.
36. Lester, B.R., and J.B. McCarthy. 1992. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion, and metastasis. Cancer Metastasis Rev. 11:31-44.
37. Pedersen, P.-H., G.O. Ness, O. Engebraaten, R. Bjerkvig, J.R. Lillehaug, and O.D. Laerum. 1994. Heterogeneous response to the growth factors EGF, PDGF (bb), TGF-α, bFGF, IL-2 on glioma spheroid growth, migration and invasion. Int. J. Cancer. 56:255-261.
38. Brooks, P.C., S. Stromblad, L.C Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, and D.A. Cheresh. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin ανβ3. Cell. 85:683-693.
39. Albelda, S.M. 1993. Biology of disease: role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68:4-17.
40. Boukerche, H., M. Benchaibi, O. Berthier-Vergnes, G. Lizard, M. Bailly, M. Bailly, and J.L. McGergor. 1994. Two human melanoma cell line variants with enhanced in vivo tumor growth and metastatic capacity do not express the β3 integrin subunit. Eur. J. Biochem. 220:485-491.
41. Lewis, J.M., D.A. Cheresh, and M.A. Schwartz. 1996. Protein kinase C regulates ανβ5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J. Cell Biol. 134:1323-1332.
42. Pasqualini, R., J. Bodorova, S. Ye, and M.E. Hemler. 1993. A study of the structure, function and distribution of β5 integrins using novel anti-β5 monoclonal antibodies. J. Cell Sci. 105:101-111.
43. Resnicoff, M., D. Ambrose, D. Coppola, and R. Rubin. 1993. Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab. Invest. 69:756-760.
44. Ambrose, D., M. Resnicoff, D. Coppola, C. Sell, M. Miura, S. Jameson, R. Baserga, and R. Rubin. 1994. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J. Cell. Physiol. 159: 92-100.
45. Otey, C.A., G.B. Vasquez, K. Burridge, and B.W. Erickson. 1993. Mapping of the α-actinin binding site within the β1 integrin cytoplasmic domain. J. Biol. Chem. 268:21193-21197.
46. Sastry, S.K., and A.F. Horwitz. 1993. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra-and intracellular initiated transmembrane signaling. Curr. Opin. Cell Biol. 5:819-831.
47. Stossel, T.P. 1993. On the crawling of animal cells. Science (Wash. DC). 260:1086-1094.
48. Albelda, S.M., S.A. Mette, D.E. Elder, P. Steward, L. Damjanovich, M. Heryln, and C.A. Buck. 1990. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res. 50:6757-6764.
49. Chambers, A.F., and A.B. Tuck. 1993. ras-resposnsive genes and tumor metastasis. Crit. Rev. Oncog. 4:95-114.
50. Rong, S., S. Segal, M. Anver, J.H. Resau, and G.F. Vande Woude. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA. 91:4731-4735.
51. Felding-Habermann, B., and D.A. Cheresh. 1993. Vitronectin and its receptors. Curr. Opin. Cell Biol. 5:864-868.